IN Brief:
- SlimFast is expanding beyond traditional weight management with seven functional-nutrition products backed by a £5m investment.
- The portfolio introduces protein, fibre, collagen, creatine, hydration, and additional weight-management formats.
- Supreme’s Trafford Park operation provides in-house health-and-wellness manufacturing as the acquired brand moves into more complex formulations.
Supreme is backing SlimFast’s expansion into functional nutrition with a £5m investment and seven new products, using its Manchester health-and-wellness manufacturing capability as the brand moves beyond its traditional weight-management position.
The new range spans protein, fibre, collagen, creatine, hydration, and weight-management products and is due to reach major retailers during August. It marks the most substantial portfolio change since Supreme acquired the UK and European SlimFast business from Glanbia for £20.1m in October 2025.
The £5m is a broader brand and portfolio investment rather than a £5m factory project. It supports the new-product programme and marketing activity, while Supreme’s separate investment in health-and-wellness manufacturing at Trafford Park gives the group more capability to develop and produce products internally.
That distinction matters because the industrial consequence comes from the number and variety of formulations entering the portfolio rather than the headline marketing spend. Supreme said when it bought SlimFast that it intended to bring powder production in-house, expand the brand internationally, and use its existing health-and-wellness expertise to broaden the range.
The seven launches include protein plus fibre in two flavours, collagen plus creatine, clear collagen protein, creatine hydration, a daily fibre product, and glucomannan weight-management capsules. SlimFast will continue selling its established 3-2-1 weight-management range alongside the new products.
Supreme already produces health-and-wellness products through VN Labs at Trafford Park. The company says more than 200,000 products are sold to retailers each month from its health-and-wellness portfolio, with much of that volume manufactured in Manchester.
Its production model covers formulation development, mixing, filling, and preparation of retail-ready products for owned brands. Supreme also states that its manufacturing operation can adjust formulations and make products to demand, giving it greater flexibility than a model dependent entirely on fixed external production runs.
That flexibility becomes more useful as SlimFast moves into several functional categories simultaneously. Protein, fibre, collagen, creatine, and electrolyte products can look commercially adjacent on a retailer’s shelf, but they behave differently inside a manufacturing process.
Powders vary in bulk density, flow characteristics, particle size, solubility, and sensitivity to moisture. Fibre can change the physical behaviour of a blend, while proteins and collagen may introduce flavour and dispersibility challenges. Creatine and electrolyte formulations depend on accurate dosing and consistent mixing, particularly where the quantity of an active ingredient forms part of the product proposition.
A wider range also increases the number of raw materials and packaging components moving through the factory. Each additional recipe creates requirements around ingredient approval, storage, weighing, batch traceability, cleaning, changeovers, labels, packaging formats, and finished-product checks.
That can make shorter production runs increasingly expensive unless the factory is designed around rapid changeovers and flexible scheduling. The benefit of internal manufacturing is therefore not simply lower unit cost; it can allow development teams to test products, alter formulations, and scale successful lines without negotiating every adjustment through a third-party manufacturer.
Supreme describes its Trafford Park products as being manufactured under tightly controlled conditions using formulations developed by its product team. The company has also invested in manufacturing infrastructure intended to improve consistency while retaining the ability to alter products as market requirements change.
The commercial reason for that flexibility is visible in SlimFast’s repositioning. Weight management remains a large category, but the brand is now competing for customers who are also buying products around protein intake, hydration, digestive health, muscle maintenance, recovery, and healthy ageing.
That creates opportunities for more consumption occasions, but it also moves SlimFast into categories already occupied by specialist sports-nutrition and supplement manufacturers. A recognised brand name does not remove the need to match those competitors on formulation, taste, convenience, price, and product credibility.
Manufacturing can become one of the ways to respond. A company able to reformulate quickly, trial new active combinations, or alter production quantities can react to changing demand without carrying as much inventory in unsuccessful formats.
The risk is complexity. Seven launches arriving together increase the number of ingredients, specifications, production instructions, and finished goods that have to be managed before sales volumes are known. A wider portfolio only improves the economics of the acquisition if the factory can absorb that variety without increasing waste, downtime, and working capital faster than revenue.
Supreme’s ownership gives SlimFast access to manufacturing skills already used across protein, vitamin, and wellness products rather than requiring those capabilities to be built from the beginning. That gives the repositioning a stronger industrial foundation than a conventional packaging and advertising refresh.
The next test is whether the new formulations generate enough repeat demand to justify the added production complexity. Supreme has the factory capability to put more products behind the SlimFast name; the harder part is determining which of those products deserve permanent space in the manufacturing schedule.
